Sign Up to like & get
recommendations!
1
Published in 2018 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000368
Abstract: Lapatinib, a tyrosine kinase inhibitor used as an anticancer therapeutic agent, has adverse events associated with treatment resulting in noncompliance and withdrawal from the therapy. Here, we performed meta-analysis of published clinical trials to determine…
read more here.
Keywords:
risk;
therapy;
patients cancer;
gastrointestinal events ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.14452
Abstract: The predictors of severe gastrointestinal (GI) events in GI lymphoma patients are unclear. We aimed to develop a risk scoring system for GI events requiring surgery.
read more here.
Keywords:
events requiring;
scoring system;
risk scoring;
lymphoma patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/1756286418768775
Abstract: Background: Gastrointestinal (GI) events are common adverse events (AEs) associated with delayed-release dimethyl fumarate (DMF), an approved treatment for relapsing–remitting multiple sclerosis (RRMS). The objective of the TOLERATE study was to evaluate GI tolerability and…
read more here.
Keywords:
study;
mitigation;
gastrointestinal events;
delayed release ... See more keywords